In the current issue:
-
Clinical aspects of trastuzumab treatment in breast cancer
Grell Peter et al. -
Adjuvant treatment for stage I of testicular germ cell tumours
Lakomý Radek et al. -
Cetuximab and Irinitecan for the treatment of metastatic colorectal cancer – pilot results from Masaryk Memorial Cancer Institute
Němeček Radim et al.
Reviews
Klin Onkol 2009; 22(1): 3-10.
Keywords: trastuzumab, breast cancer, proto-oncogene protein HER-2, treatment effi cacy, drug toxicity
Authors: Grell Peter, Svoboda Marek, Fabián Pavel, Petráková Katarína, Vyzula Rostislav2009-02-15:Clinical aspects of trastuzumab treatment in breast cancer
Keywords: trastuzumab, breast cancer, proto-oncogene protein HER-2, treatment effi cacy, drug toxicity
Authors: Grell Peter, Svoboda Marek, Fabián Pavel, Petráková Katarína, Vyzula Rostislav2009-02-15:Clinical aspects of trastuzumab treatment in breast cancer
Klin Onkol 2009; 22(1): 11-16.
Keywords: tumor stem cells, plasticity, diversity, microenviroment, carcinogenesis
Authors: Ansorgová Veronika, Pleskačová (Mačingová) Zuzana, Priester Peter, Mokrý Jaroslav, Filip Stanislav2009-02-15:Tumor stem cells and ´niche´ – a limiting factors af the carcinogenesis
Keywords: tumor stem cells, plasticity, diversity, microenviroment, carcinogenesis
Authors: Ansorgová Veronika, Pleskačová (Mačingová) Zuzana, Priester Peter, Mokrý Jaroslav, Filip Stanislav2009-02-15:Tumor stem cells and ´niche´ – a limiting factors af the carcinogenesis
Original articles
Klin Onkol 2009; 22(1): 17-21.
Keywords: cardiotoxicity, left ventricular ejection fraction (LVEF), neoadjuvant chemoterapy adjuvant chemotherapy, radiotherapy.
Authors: Bustová Ivana2009-02-15:Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III
Keywords: cardiotoxicity, left ventricular ejection fraction (LVEF), neoadjuvant chemoterapy adjuvant chemotherapy, radiotherapy.
Authors: Bustová Ivana2009-02-15:Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III
Klin Onkol 2009; 22(1): 22-26.
Keywords: Testicular cancer, chemotherapy, radiotherapy, disease management, relapse, risk factors
Authors: Lakomý Radek, Poprach Alexandr, Němeček Radim, Vyskočil Jiří, Ondrová Barbora, Kocák Ivo, Kocáková Ilona, Řehák Zdeněk2009-02-15:Adjuvant treatment for stage I of testicular germ cell tumours
Keywords: Testicular cancer, chemotherapy, radiotherapy, disease management, relapse, risk factors
Authors: Lakomý Radek, Poprach Alexandr, Němeček Radim, Vyskočil Jiří, Ondrová Barbora, Kocák Ivo, Kocáková Ilona, Řehák Zdeněk2009-02-15:Adjuvant treatment for stage I of testicular germ cell tumours
Klin Onkol 2009; 22(1): 27-33.
Keywords: cetuximab, irinotecan, colorectal cancer.
Authors: Němeček Radim, Kocáková Ilona, Kocák Ivo, Svoboda Marek, Lakomý Radek, Poprach Alexandr, Vyskočil Jiří, Vyzula Rostislav2009-02-15:Cetuximab and Irinitecan for the treatment of metastatic colorectal cancer – pilot results from Masaryk Memorial Cancer Institute
Keywords: cetuximab, irinotecan, colorectal cancer.
Authors: Němeček Radim, Kocáková Ilona, Kocák Ivo, Svoboda Marek, Lakomý Radek, Poprach Alexandr, Vyskočil Jiří, Vyzula Rostislav2009-02-15:Cetuximab and Irinitecan for the treatment of metastatic colorectal cancer – pilot results from Masaryk Memorial Cancer Institute
Case report
Klin Onkol 2009; 22(1): 34-37.
Keywords: anthracyclines, cardiotoxicity, cardiomyopathy, heart transplantation
Authors: Urbanová Dagmar, Bubanská Eva, Hrebík M., Mladosievičová Beáta2009-02-15:Severe heart failure in consequence of late anthracycline-induced cardiotoxicity – case report
Keywords: anthracyclines, cardiotoxicity, cardiomyopathy, heart transplantation
Authors: Urbanová Dagmar, Bubanská Eva, Hrebík M., Mladosievičová Beáta2009-02-15:Severe heart failure in consequence of late anthracycline-induced cardiotoxicity – case report
Report
Klin Onkol 2009; 22(1): 38-39.
2009-02-15:Report
2009-02-15:Report
Oncological association
Klin Onkol 2009; 22(1): 40.
2009-02-15:Oncological associations
2009-02-15:Oncological associations
